Since the introduction of PSA testing in 1988, Australia has demonstrated higher rates of negative transrectal ultrasound-guided systemic biopsies and a higher incidence of low/intermediate grade prostate cancer in males younger than 55 in which cases would have gone previously undetected [25]. Here, KLK3 is linked to prostate cancer.